Flot-2, as a target gene of p63 and p73, member of the p53 transcription factor family [24], has been proposed as a prognostic marker linked to poor prognosis in several human tumors, such as breast cancer, gastric cancer, cervical carcinoma and so on [11–13]. This evidence concerns the gene FLOT2 and breast carcinoma.